SAN DIEGO, April 22, 2026 (GLOBE NEWSWIRE)-- BlossomHill Therapeutics, Inc., a privately-held, clinical-stage biopharmaceutical company applying an intentional, chemistry-based approach to develop ...
The American Association for Cancer Research (AACR) meeting kicks off this weekend, in San Diego, California. The event is a whirlwind of sessions, keynotes, mini-symposia, posters and exhibitors. How ...
Data to showcase PROphet® platform's machine learning models for predicting therapeutic benefit and immune-related adverse events in non-small cell lung cancer patients treated with immunotherapy ...
SOUTH SAN FRANCISCO, Calif., March 18, 2026 (GLOBE NEWSWIRE)-- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical-stage biotechnology company focused on the discovery and development of ...
BH-501284 demonstrated high potency (median IC50 of 0.83 nM) and prolonged residence time (>54 hours) in KRAS-mutant cell lines, offering unique pseudo-irreversible target inhibition Mutant selective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results